Madely Health Headlines Commentary for March , 2013
MS drug study: Beware drug company press releases that are used to report drug trial results, and of course it has favourable resultsPlay Now | Play in Popup | Download
The results were presented at the American Academy of Neurology’s 65th Annual Meeting. It is not published.
Further it compares the drug to placebo, a useless marker for clinicians. We want to know how it fares against other medication of a similar class at least and how it compares to other medication in use today. It also refers to relative and not absolute risk reduction.
Madely Health Headlines Commentary for January 29, 2013
No new antibiotics on the horizon to combat increasing bacterial resistance from indiscriminate use in humans and farm animalsPlay Now | Play in Popup | Download
Madely Health Headlines Commentary for January 10, 2013
Government digging into Tamiflu stockpile to combat flu; unfortunately evidence that the drug works as purported by drug company is being questionedPlay Now | Play in Popup | Download
Source: Trojan-horse therapy ‘completely eliminates’ cancer in mice Reference: Macrophage Delivery of an Oncolytic Virus Abolishes Tumor Regrowth and Metastasis After Chemotherapy or Irradiation
Madely Health Headlines Commentary for November 5, 2012
Prescription drugs and herbal remedies follow the same science of drug interactions and can negatively affect health outcomesPlay Now | Play in Popup | Download
This press release does not cite published studies. Nor do we know if there were negative outcomes in other clinical trials. THere is no obligation on the part of pharma to release details of stiudies that cast a negative outcome for their product.
Heike A. Bischoff-Ferrari, Walter C. Willett, Endel J. Orav, Paul Lips, Pierre J. Meunier, Ronan A. Lyons, Leon Flicker, John Wark, Rebecca D. Jackson, Jane A. Cauley, Haakon E. Meyer, Michael Pfeifer, Kerrie M. Sanders, Hannes B. Stähelin, Robert Theiler, Bess Dawson-Hughes. A Pooled Analysis of Vitamin D Dose Requirements for Fracture Prevention. New England Journal of Medicine, 2012; 367 (1): 40 DOI: 10.1056/NEJMoa1109617